Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Invested Capital: 2013-2024

Historic Return on Invested Capital for Amphastar Pharmaceuticals (AMPH) over the last 11 years, with Dec 2024 value amounting to 0.15%.

  • Amphastar Pharmaceuticals' Return on Invested Capital fell 6.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of 0.15% for FY2024, which is 4.00% down from last year.
  • As of FY2024, Amphastar Pharmaceuticals' Return on Invested Capital stood at 0.15%, which was down 18.81% from 0.19% recorded in FY2023.
  • Amphastar Pharmaceuticals' Return on Invested Capital's 5-year high stood at 0.19% during FY2023, with a 5-year trough of 0.01% in FY2020.
  • Its 3-year average for Return on Invested Capital is 0.16%, with a median of 0.15% in 2024.
  • As far as peak fluctuations go, Amphastar Pharmaceuticals' Return on Invested Capital climbed by 10bps in 2021, and later dropped by 4bps in 2024.
  • Amphastar Pharmaceuticals' Return on Invested Capital (Yearly) stood at 0.01% in 2020, then rose by 10bps to 0.11% in 2021, then climbed by 3bps to 0.13% in 2022, then grew by 5bps to 0.19% in 2023, then dropped by 4bps to 0.15% in 2024.